drugset / Trial / NCT06683014

MDMA in Borderline Personality Disorder

NCT06683014 ↗

NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to test the effects of MDMA (3,4-methylenedioxymethamphetamine) on social cognition in adults with Borderline Personality Disorder.

Timeline

Start
2025-09-05
Primary completion
2026-09
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Subject MDMA Unknown — —